{
  "trial_id": "NCT00896181",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race/ethnicity, ECOG performance status, stage of disease, histological type, absolute neutrophil count (ANC), platelet count, total bilirubin, AST/ALT levels, creatinine levels, hearing loss grade, peripheral neuropathy grade, prior diagnostic surgery, life expectancy, use of effective contraception.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex",
          "sex"
        ],
        [
          "Age",
          "Age"
        ],
        [
          "Disease Stage",
          "stage of disease"
        ]
      ],
      "remaining_reference_features": [
        "Tumor T category",
        "Tumor N category",
        "Tumor M category"
      ],
      "remaining_candidate_features": [
        "race/ethnicity",
        "ECOG performance status",
        "histological type",
        "absolute neutrophil count (ANC)",
        "platelet count",
        "total bilirubin",
        "AST/ALT levels",
        "creatinine levels",
        "hearing loss grade",
        "peripheral neuropathy grade",
        "prior diagnostic surgery",
        "life expectancy",
        "use of effective contraception."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Sex, Race, ECOG performance status, Stage of disease, Histological type, Measurable disease status, Absolute neutrophil count (ANC), Platelet count, Total bilirubin, AST/ALT levels, Creatinine levels, Hearing loss grade, Peripheral neuropathy grade, Prior diagnostic surgery, Life expectancy, Fertility status, Use of effective contraception",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex",
          "Sex"
        ],
        [
          "Age",
          "Age"
        ],
        [
          "Disease Stage",
          "Stage of disease"
        ]
      ],
      "remaining_reference_features": [
        "Tumor T category",
        "Tumor N category",
        "Tumor M category"
      ],
      "remaining_candidate_features": [
        "Race",
        "ECOG performance status",
        "Histological type",
        "Measurable disease status",
        "Absolute neutrophil count (ANC)",
        "Platelet count",
        "Total bilirubin",
        "AST/ALT levels",
        "Creatinine levels",
        "Hearing loss grade",
        "Peripheral neuropathy grade",
        "Prior diagnostic surgery",
        "Life expectancy",
        "Fertility status",
        "Use of effective contraception"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Sex, Ethnic Origin, ECOG performance status, Histological type of nasopharyngeal carcinoma, Tumor stage, Nodal stage, Metastatic stage, Prior diagnostic surgery, Absolute neutrophil count, Platelet count, Total bilirubin, Aspartate aminotransferase, Alanine aminotransferase, Creatinine, Creatinine clearance, Hearing loss, Peripheral motor/sensory neuropathy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex",
          "Sex"
        ],
        [
          "Age",
          "Age"
        ],
        [
          "Tumor T category",
          "Tumor stage"
        ],
        [
          "Tumor N category",
          "Nodal stage"
        ],
        [
          "Tumor M category",
          "Metastatic stage"
        ],
        [
          "Disease Stage",
          "Histological type of nasopharyngeal carcinoma"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "Ethnic Origin",
        "ECOG performance status",
        "Prior diagnostic surgery",
        "Absolute neutrophil count",
        "Platelet count",
        "Total bilirubin",
        "Aspartate aminotransferase",
        "Alanine aminotransferase",
        "Creatinine",
        "Creatinine clearance",
        "Hearing loss",
        "Peripheral motor/sensory neuropathy"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, WHO type (I, II, or III), stage of disease (II, III, or IV), tumor size, nodal status, presence of metastases, prior surgery, prior chemotherapy, prior radiotherapy, ANC, platelet count, total bilirubin, AST, ALT, creatinine, creatinine clearance, hearing loss, peripheral neuropathy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex",
          "sex"
        ],
        [
          "Age",
          "Age"
        ],
        [
          "Tumor T category",
          "tumor size"
        ],
        [
          "Tumor N category",
          "nodal status"
        ],
        [
          "Tumor M category",
          "presence of metastases"
        ],
        [
          "Disease Stage",
          "stage of disease (II, III, or IV)"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "ECOG performance status",
        "WHO type (I, II, or III)",
        "prior surgery",
        "prior chemotherapy",
        "prior radiotherapy",
        "ANC",
        "platelet count",
        "total bilirubin",
        "AST",
        "ALT",
        "creatinine",
        "creatinine clearance",
        "hearing loss",
        "peripheral neuropathy"
      ]
    }
  }
}